SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Rochesteron Lynn)
 

Search: WFRF:(Rochesteron Lynn) > (2018) > Gait in Mild Alzhei...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Mc Ardle, Ríona (author)

Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.

  • Article/chapterEnglish2018

Publisher, publication year, extent ...

  • 2018

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/265749
  • https://gup.ub.gu.se/publication/265749URI
  • https://doi.org/10.3233/JAD-171116DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Gait is emerging as a potential diagnostic tool for cognitive decline. The 'Deep and Frequent Phenotyping for Experimental Medicine in Dementia Study' (D&FP) is a multicenter feasibility study embedded in the United Kingdom Dementia Platform designed to determine participant acceptability and feasibility of extensive and repeated phenotyping to determine the optimal combination of biomarkers to detect disease progression and identify early risk of Alzheimer's disease (AD). Gait is included as a clinical biomarker. The tools to quantify gait in the clinic and home, and suitability for multi-center application have not been examined. Six centers from the National Institute for Health Research Translational Research Collaboration in Dementia initiative recruited 20 individuals with early onset AD. Participants wore a single wearable (tri-axial accelerometer) and completed both clinic-based and free-living gait assessment. A series of macro (behavioral) and micro (spatiotemporal) characteristics were derived from the resultant data using previously validated algorithms. Results indicate good participant acceptability, and potential for use of body-worn sensors in both the clinic and the home. Recommendations for future studies have been provided. Gait has been demonstrated to be a feasible and suitable measure, and future research should examine its suitability as a biomarker in AD.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Morris, Rosie (author)
  • Hickey, Aodhán (author)
  • Del Din, Silvia (author)
  • Koychev, Ivan (author)
  • Gunn, Roger N (author)
  • Lawson, Jennifer (author)
  • Zamboni, Giovanna (author)
  • Ridha, Basil (author)
  • Sahakian, Barbara J (author)
  • Rowe, James B (author)
  • Thomas, Alan (author)
  • Zetterberg, Henrik,1973Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry(Swepub:gu)xzethe (author)
  • MacKay, Clare (author)
  • Lovestone, Simon (author)
  • Rochesteron, Lynn (author)
  • Göteborgs universitetInstitutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi (creator_code:org_t)

Related titles

  • In:Journal of Alzheimer's disease : JAD63:1, s. 331-3411875-8908

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view